Understanding your GLP-1 dosing schedule and titration plan is essential for maximizing results while minimizing side effects. Every GLP-1 medication follows a gradual dose-escalation protocol designed to help your body adjust. Rushing the titration can lead to severe nausea and other gastrointestinal side effects, while going too slowly may delay your results. This comprehensive GLP-1 dosing guide covers titration schedules for every major medication, what to expect at each dose level, and when to adjust.
Why GLP-1 Medications Require Titration
Titration — the process of gradually increasing a medication dose — is used with all GLP-1 receptor agonists for several reasons:
- Minimize side effects: Nausea, vomiting, and other GI side effects are dose-dependent. Starting low allows your body to adapt.
- Assess tolerance: Your provider can evaluate how you respond before increasing to higher doses.
- Optimize outcomes: The right dose balances effectiveness with tolerability.
- Safety: Gradual increases reduce the risk of severe adverse events.
Skipping the titration or increasing doses faster than recommended can lead to severe nausea, vomiting, diarrhea, and even dehydration requiring medical attention.
Ozempic (Semaglutide) Dosing Schedule
Ozempic is FDA-approved for type 2 diabetes and comes in a multi-dose injection pen.
Standard Titration
| Phase | Dose | Duration | Purpose |
|---|---|---|---|
| Starting dose | 0.25 mg weekly | 4 weeks | Adaptation period (not a therapeutic dose) |
| Dose 2 | 0.5 mg weekly | 4+ weeks | First therapeutic dose; assess response |
| Dose 3 | 1.0 mg weekly | 4+ weeks | Standard therapeutic dose for most patients |
| Dose 4 | 2.0 mg weekly | Maintenance | Maximum dose for additional blood sugar control |
Key Notes
- 0.25 mg is not a treatment dose — it's purely for titration. Expect minimal weight loss or blood sugar improvement at this level.
- Most patients settle at 0.5 mg or 1.0 mg for diabetes management.
- The 2.0 mg dose is available for additional glycemic control if needed.
- Minimum 4 weeks at each dose before increasing; your provider may extend this if side effects are significant.
Ozempic Pen Options
- 0.25 mg / 0.5 mg pen: Contains enough for the first 8 weeks of titration
- 1.0 mg pen: For the 1.0 mg maintenance dose
- 2.0 mg pen: For the maximum dose
Wegovy (Semaglutide) Dosing Schedule
Take our quick eligibility quiz to find out if you may qualify.
Wegovy is FDA-approved for weight management and uses a longer, more gradual titration than Ozempic.
Standard Titration
| Phase | Dose | Duration | Purpose |
|---|---|---|---|
| Month 1 | 0.25 mg weekly | Weeks 1–4 | Initial adaptation |
| Month 2 | 0.5 mg weekly | Weeks 5–8 | Continued adaptation |
| Month 3 | 1.0 mg weekly | Weeks 9–12 | Intermediate dose |
| Month 4 | 1.7 mg weekly | Weeks 13–16 | Pre-maintenance dose |
| Month 5+ | 2.4 mg weekly | Week 17 onward | Full maintenance dose |
Key Notes
- Total titration period: 16–20 weeks before reaching maintenance dose
- Each dose level uses a separate pen with a different color and dose setting
- Meaningful weight loss typically begins around the 1.0 mg dose level
- Maximum results are usually seen at the 2.4 mg maintenance dose
- Your provider may extend any titration step if side effects are bothersome
Mounjaro (Tirzepatide) Dosing Schedule
Mounjaro is FDA-approved for type 2 diabetes and targets both GLP-1 and GIP receptors.
Standard Titration
| Phase | Dose | Duration | Purpose |
|---|---|---|---|
| Starting dose | 2.5 mg weekly | 4 weeks | Adaptation (not therapeutic) |
| Dose 2 | 5.0 mg weekly | 4+ weeks | First therapeutic dose |
| Dose 3 | 7.5 mg weekly | 4+ weeks | Intermediate dose |
| Dose 4 | 10.0 mg weekly | 4+ weeks | Higher therapeutic dose |
| Dose 5 | 12.5 mg weekly | 4+ weeks | Advanced dose |
| Dose 6 | 15.0 mg weekly | Maintenance | Maximum dose |
Key Notes
- More dose options than semaglutide, allowing finer-tuned titration
- 2.5 mg is not a treatment dose — purely for adaptation
- Many patients see excellent results at 5.0–10.0 mg and may not need the maximum dose
- Each dose level uses a separate pen identified by color
- Minimum 4 weeks at each dose before increasing
Zepbound (Tirzepatide) Dosing Schedule
Zepbound uses the same active ingredient as Mounjaro but is FDA-approved for weight management.
Standard Titration
| Phase | Dose | Duration | Purpose |
|---|---|---|---|
| Starting dose | 2.5 mg weekly | 4 weeks | Adaptation |
| Dose 2 | 5.0 mg weekly | 4 weeks | First therapeutic dose |
| Dose 3 | 7.5 mg weekly | 4 weeks | Continue titration |
| Dose 4 | 10.0 mg weekly | 4 weeks | Continue titration |
| Dose 5 | 12.5 mg weekly | 4 weeks | Pre-maintenance |
| Dose 6 | 15.0 mg weekly | Maintenance | Maximum dose |
Key Notes
- Identical titration to Mounjaro — same medication, different indication
- Full titration to 15 mg takes approximately 20–24 weeks
- Maximum weight loss results are typically seen at 10.0–15.0 mg
- Provider may stop titration at a lower dose if results are satisfactory
Saxenda (Liraglutide) Dosing Schedule
Take our quick eligibility quiz to find out if you may qualify.
Saxenda is FDA-approved for weight management and requires daily injections.
Standard Titration
| Week | Dose | Frequency |
|---|---|---|
| Week 1 | 0.6 mg | Daily |
| Week 2 | 1.2 mg | Daily |
| Week 3 | 1.8 mg | Daily |
| Week 4 | 2.4 mg | Daily |
| Week 5+ | 3.0 mg | Daily (maintenance) |
Key Notes
- Fastest titration among FDA-approved weight loss GLP-1s (4 weeks to full dose)
- Daily dosing — more frequent than weekly options
- If you can't tolerate 3.0 mg, your provider may keep you at 2.4 mg
- If you haven't lost ≥4% body weight by 16 weeks at 3.0 mg, guidelines suggest discontinuing
Rybelsus (Oral Semaglutide) Dosing Schedule
Rybelsus is the only oral GLP-1 medication, FDA-approved for type 2 diabetes.
Standard Titration
| Phase | Dose | Duration |
|---|---|---|
| Starting dose | 3 mg daily | 30 days |
| Dose 2 | 7 mg daily | 30+ days |
| Dose 3 | 14 mg daily | Maintenance |
Key Notes
- Must be taken on an empty stomach with no more than 4 oz of plain water
- Wait 30 minutes before eating, drinking, or taking other medications
- 3 mg is not a treatment dose — purely for GI adaptation
- Each dose is a different tablet — not adjustable like injection pens
What to Expect at Each Titration Phase
Starting Dose (Weeks 1–4)
Physical changes:
- Little to no weight loss expected
- Mild appetite reduction in some patients
- Possible mild nausea, stomach discomfort, or changes in bowel habits
- Your body is adjusting — this is the adaptation phase
What to do:
- Start practicing healthy eating habits
- Begin or continue an exercise routine
- Stay hydrated
- Keep a symptom journal
Early Therapeutic Doses (Weeks 5–12)
Physical changes:
- Appetite suppression becomes more noticeable
- Weight loss typically begins
- Nausea may temporarily worsen with each dose increase
- Food preferences may start shifting (less interest in high-fat/high-sugar foods)
What to do:
- Eat smaller meals more frequently
- Prioritize protein intake
- Manage nausea with recommended strategies
- Report persistent side effects to your provider
Higher and Maintenance Doses (Weeks 12+)
Physical changes:
- Significant appetite reduction
- Consistent weight loss
- GI side effects typically improving or resolved
- Increased energy as weight decreases
What to do:
- Ensure adequate protein intake (0.7–1.0g per lb body weight)
- Maintain regular exercise, including strength training
- Continue regular check-ins with your provider
- Monitor for any new side effects
When to Delay or Slow Titration
Take our quick eligibility quiz to find out if you may qualify.
Signs You May Need More Time at a Dose
- Persistent nausea or vomiting that significantly impacts daily life
- Inability to eat or drink adequately
- Severe GI side effects that aren't improving
- Dehydration symptoms (dark urine, dizziness, dry mouth)
What Your Provider May Recommend
- Stay at your current dose for an additional 4–8 weeks before increasing
- Step back to a lower dose if a higher dose is intolerable
- Add anti-nausea medication to help manage side effects during titration
- Switch to a different GLP-1 medication if side effects persist across multiple dose levels
Common Dosing Questions and Mistakes
Missed Dose Protocols
Weekly injections (Ozempic, Wegovy, Mounjaro, Zepbound):
- If ≤2 days late: Take the dose as soon as possible, then resume your normal schedule
- If >2 days late for semaglutide (or >3 days for tirzepatide): Skip the missed dose and take the next dose on schedule
- Never take two doses to make up for a missed one
Daily injections (Saxenda):
- Skip the missed dose; take the next one at the normal time
- Do not double up
Daily oral (Rybelsus):
- Skip the missed dose; take the next one the following morning
- Do not take two tablets to make up for a missed dose
Choosing Your Injection Day and Time
- Pick a consistent day of the week for weekly injections
- Any time of day is acceptable for weekly injections
- You can change your injection day — just ensure at least 2 days (48 hours) between doses
- Some patients prefer evening injections to sleep through any nausea
Frequently Asked Questions
Can I increase my GLP-1 dose faster than recommended?
This is strongly discouraged. The titration schedule is specifically designed to minimize side effects and allow your body to adjust. Increasing too quickly can cause severe nausea, vomiting, and dehydration. In rare cases, rapid dose escalation may increase the risk of pancreatitis or other serious adverse events. Always follow your provider's recommended schedule.
What if I feel fine on a lower dose — do I still need to increase?
Not necessarily. If you're achieving satisfactory weight loss or blood sugar control at a lower dose with tolerable side effects, your provider may recommend staying there. Higher doses produce more weight loss on average, but the right dose is the one that balances effectiveness with tolerability for your individual situation.
Why did my nausea come back when I increased my dose?
This is completely normal and expected. Each dose increase introduces more of the medication into your system, and your body needs time to adjust. Nausea typically peaks in the first 1–2 weeks after a dose increase and then subsides. Use the same management strategies that helped during your initial titration (small meals, bland foods, ginger, hydration).
Can my doctor prescribe a dose that's between the standard levels?
For injectable GLP-1 medications, doses are pre-set in the pens and can't typically be adjusted between standard levels. However, for compounded semaglutide, custom doses are possible. Some providers may also recommend splitting doses or adjusting frequency in specific situations, though this is off-label and should only be done under medical supervision.
How long does it take for GLP-1 medications to reach full effect?
Most patients see the full appetite-suppressing and weight-loss effects once they reach their maintenance dose and have been on it for 4–8 weeks. Maximum weight loss typically occurs over 12–18 months of treatment. Blood sugar improvements may be noticeable earlier in the titration process for diabetic patients.
Taking the Next Step
Take our quick eligibility quiz to find out if you may qualify.
Proper dosing and titration are fundamental to a successful GLP-1 treatment experience. Understanding what to expect at each stage, communicating with your provider about side effects, and following the recommended schedule will help you achieve the best possible results.
Ready to explore your options? Take our free eligibility quiz →
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.
Take our 2-minute eligibility quiz and connect with a licensed telehealth provider.
⚕️ Medical Disclaimer
This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. Individual results vary. GLP-1 medications are prescription drugs and should only be used under medical supervision.